QQQ   431.63 (+0.13%)
AAPL   172.70 (+0.01%)
MSFT   416.72 (+0.74%)
META   503.73 (+0.70%)
GOOGL   154.84 (-0.01%)
AMZN   183.86 (+0.13%)
TSLA   155.03 (-3.99%)
NVDA   873.70 (+1.59%)
AMD   162.80 (+1.55%)
NIO   3.79 (-2.57%)
BABA   69.63 (-1.40%)
T   16.06 (-1.11%)
F   12.10 (-1.06%)
MU   119.46 (-1.57%)
GE   154.98 (+0.83%)
CGC   6.73 (-3.58%)
DIS   112.92 (-0.03%)
AMC   2.49 (+0.81%)
PFE   25.85 (-0.23%)
PYPL   63.20 (-0.49%)
XOM   119.07 (-0.51%)
QQQ   431.63 (+0.13%)
AAPL   172.70 (+0.01%)
MSFT   416.72 (+0.74%)
META   503.73 (+0.70%)
GOOGL   154.84 (-0.01%)
AMZN   183.86 (+0.13%)
TSLA   155.03 (-3.99%)
NVDA   873.70 (+1.59%)
AMD   162.80 (+1.55%)
NIO   3.79 (-2.57%)
BABA   69.63 (-1.40%)
T   16.06 (-1.11%)
F   12.10 (-1.06%)
MU   119.46 (-1.57%)
GE   154.98 (+0.83%)
CGC   6.73 (-3.58%)
DIS   112.92 (-0.03%)
AMC   2.49 (+0.81%)
PFE   25.85 (-0.23%)
PYPL   63.20 (-0.49%)
XOM   119.07 (-0.51%)
QQQ   431.63 (+0.13%)
AAPL   172.70 (+0.01%)
MSFT   416.72 (+0.74%)
META   503.73 (+0.70%)
GOOGL   154.84 (-0.01%)
AMZN   183.86 (+0.13%)
TSLA   155.03 (-3.99%)
NVDA   873.70 (+1.59%)
AMD   162.80 (+1.55%)
NIO   3.79 (-2.57%)
BABA   69.63 (-1.40%)
T   16.06 (-1.11%)
F   12.10 (-1.06%)
MU   119.46 (-1.57%)
GE   154.98 (+0.83%)
CGC   6.73 (-3.58%)
DIS   112.92 (-0.03%)
AMC   2.49 (+0.81%)
PFE   25.85 (-0.23%)
PYPL   63.20 (-0.49%)
XOM   119.07 (-0.51%)
QQQ   431.63 (+0.13%)
AAPL   172.70 (+0.01%)
MSFT   416.72 (+0.74%)
META   503.73 (+0.70%)
GOOGL   154.84 (-0.01%)
AMZN   183.86 (+0.13%)
TSLA   155.03 (-3.99%)
NVDA   873.70 (+1.59%)
AMD   162.80 (+1.55%)
NIO   3.79 (-2.57%)
BABA   69.63 (-1.40%)
T   16.06 (-1.11%)
F   12.10 (-1.06%)
MU   119.46 (-1.57%)
GE   154.98 (+0.83%)
CGC   6.73 (-3.58%)
DIS   112.92 (-0.03%)
AMC   2.49 (+0.81%)
PFE   25.85 (-0.23%)
PYPL   63.20 (-0.49%)
XOM   119.07 (-0.51%)
LON:IDP

InnovaDerma (IDP) Share Price, News & Analysis

GBX 29
0.00 (0.00%)
(As of 05/30/2022)
Today's Range
28.66
29
50-Day Range
29
29
52-Week Range
25
45.50
Volume
5,000 shs
Average Volume
106,039 shs
Market Capitalization
£8.14 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
IDP stock logo

About InnovaDerma Stock (LON:IDP)

InnovaDerma PLC, through its subsidiaries, engages in the research, manufacture, and marketing of clinically proven products in life sciences, beauty, and personal care products in the United Kingdom, the United States, Australasia, and the Asia Pacific region. The company offers a range of men's skincare products, including hand and body washes, hand creams, face washes, and face moisturizers under the Charles + Lee brand name; and hair removal wax and jelly, and shave and shower sorbet under the Nuthing brand. It also provides tanning mousses, tanning gels, tanning oils, primers, moisturizers, and applicators under the Skinny Tan brand name; Prolong, a Class II medical device for the treatment of premature ejaculation; haircare products comprising shampoos, conditioners, and spray treatment for men and women to aid hair regrowth and hair thickening under the Roots brand name; and hair growth products under the GrowLase brand. The company sells its products through online and DTC channels. InnovaDerma PLC was incorporated in 2014 and is headquartered in London, the United Kingdom.

IDP Stock Price History

IDP Stock News Headlines

IDP Education: IDP to acquire Intake Education
Did You Get Your Free Bitcoin Yet?
And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.
See More Headlines
Receive IDP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for InnovaDerma and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
9/30/2020
Today
4/16/2024

Industry, Sector and Symbol

Industry
Specialty Retail
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
38
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£9.82 million
Cash Flow
GBX 4.90 per share
Book Value
GBX 7.90 per share

Miscellaneous

Free Float
N/A
Market Cap
£8.14 million
Optionable
Not Optionable
Beta
N/A
7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Key Executives

  • Mr. Blake G. Hughes
    CEO & Exec. Director
  • Mr. Andrew Dunderdale
    Group Fin. Director & Exec. Director
  • Mr. Warren Dockary
    Group Financial Controller

IDP Stock Analysis - Frequently Asked Questions

How have IDP shares performed in 2024?

InnovaDerma's stock was trading at GBX 29 at the start of the year. Since then, IDP shares have increased by 0.0% and is now trading at GBX 29.
View the best growth stocks for 2024 here
.

How were InnovaDerma's earnings last quarter?

InnovaDerma PLC (LON:IDP) posted its earnings results on Wednesday, September, 30th. The company reported ($2.00) EPS for the quarter, missing analysts' consensus estimates of $9.50 by $11.50.

What other stocks do shareholders of InnovaDerma own?

Based on aggregate information from My MarketBeat watchlists, some companies that other InnovaDerma investors own include Sol-Gel Technologies (SLGL), Synovus Financial (SNV), Venator Materials (VNTR), BJ's Restaurants (BJRI), Christopher & Banks (CBK), Cidara Therapeutics (CDTX), eHealth (EHTH), Teledyne FLIR (FLIR), Imperial Brands (IMB) and ImmunoGen (IMGN).

How do I buy shares of InnovaDerma?

Shares of IDP stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

This page (LON:IDP) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners